Global Atopic Dermatitis (AD) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431912
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • AbbieVie Inc.
  • Encore Dermatology Inc.
  • F. Hoffmann-La Roche AG
  • Glaxosmithkline plc.
  • LEO Pharma A/S
  • Novartis AG
  • MORE
Atopic Dermatitis (AD) Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global atopic dermatitis (AD) treatment market was valued at US$ 4.04 Bn in 2016, and is expected to reach US$ 7.66 Bn by 2025, expanding at a CAGR of 7.4% from 2017 to 2025.

Market Insights

Atopic dermatitis is also known as atopic eczema, it is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. It affects people of all ages but more common among infants and children. Risk factors for atopic dermatitis are mainly categorized as modifiable and non-modifiable. Modifiable risk factors include inhalant and food allergens however, non-modifiable risk factors include genetics or heritability. For the purpose of the study AD treatment market is segmented on the basis of drug type such as anti-inflammatory agents, antihistamines, immunomodulators, interleukin inhibitors, topical phosphodiesterase-4 (PDE-4) inhibitors, antiviral agents and antibiotics. It is observed that currently anti-inflammatory agents is major revenue generating segment as these drugs are preferably used as a first line therapy after failure of skin care and moisturizers due to its effectiveness. Strong pipeline molecules such as ABT-494, apremilast, LY-3009104, GSK-2894512, REGN-668, GBR-830, MEDI-9929, nemolizumab, OPA-15406, PF-04965842, secukinumab and tralokinumab are expected to show AD treatment market growth during forecast period 2017-2025. In the base year 2016, North America dominated the global AD treatment market due to large number of target population, higher treatment awareness, swift adoption of novel medications, and better reimbursement policies. On the other hand, Asia Pacific will show highest AD treatment market growth during forecast period due to increasing healthcare awareness among general population and growing partnership of key players with local manufacturer.

Market Competition Assessment

The atopic dermatitis (AD) treatment market is observed to be highly competitive and comprises large number of players. However, some major market players are LEO Pharma A/S, AbbVie Inc., Encore Dermatology Inc., F. Hoffmann-La Roche AG, Glaxosmithkline plc., Medimmune (Astrazeneca), Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Valeant Pharmaceuticals Inc. and other.

Key Market Movements:
  • Factors such as increase in prevalence of atopic dermatitis, higher treatment compliance, growing prevalence of food allergies exacerbating atopic dermatitis and favorable reimbursement policies in some countries are driving the market growth of AD treatment worldwide.
  • Due to the higher number of unmet needs, vendors in the market are focusing in developing ideal treatment, promising pipeline molecule, rising access for the treatment medication in some developing countries, increase in incidence of atopic dermatitis would fuel the growth of AD treatment market during forecast period.
  • However, generic erosion, poor patient compliance in some countries and adverse effects associated with the use of medication is negatively impacting the growth of AD treatment market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbieVie Inc.
  • Encore Dermatology Inc.
  • F. Hoffmann-La Roche AG
  • Glaxosmithkline plc.
  • LEO Pharma A/S
  • Novartis AG
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Atopic Dermatitis (AD) Treatment Market Snapshot
2.2 Global Atopic Dermatitis (AD) Treatment Market, by Drug Type
2.3 Global Atopic Dermatitis (AD) Treatment Market Share, by Geography, 2016 (Value %)

Chapter 3 Atopic Dermatitis (AD) Treatment Market Analysis
3.1 Global Atopic Dermatitis (AD) Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Pipeline Analysis of Atopic Dermatitis (AD) Treatment Drugs
3.4 Global Epidemiology of Atopic Dermatitis (AD)
3.5 Attractive Investment Proposition
3.6 Competitive Landscape of Key Players in Atopic Dermatitis (AD) Treatment Market

Chapter 4 Global Atopic Dermatitis (AD) Treatment Market, by Drug Type
4.1 Overview
4.2 Attractive Investment Proposition: Global Atopic Dermatitis (AD) Treatment Market, by Drug Type
4.3 Top 3 Countries
4.4 Anti-inflammatory agents
4.4.1 Corticosteroids
4.4.2 Calcineurin Inhibitors
4.5 Antihistamines
4.6 Immunomodulators
4.7 Interleukin Inhibitors
4.8 Topical Phosphodiesterase-4 (PDE-4) Inhibitors
4.9 Antiviral agents
4.10 Antibiotics

Chapter 5 Global Atopic Dermatitis (AD) Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015- 2025 (US$)
5.2.2 North America Atopic Dermatitis (AD) Treatment Market, by Country, 2015- 2025 (US$)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015- 2025 (US$)
5.3.2 Europe Atopic Dermatitis (AD) Treatment Market, by Country, 2015- 2025 (US$)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.4.1 Asia Pacific Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015- 2025 (US$)
5.4.1 Asia Pacific Atopic Dermatitis (AD) Treatment Market, by Country, 2015- 2025 (US$)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015- 2025 (US$)
5.5.2 Latin America Atopic Dermatitis (AD) Treatment Market, by Country, 2015- 2025 (US$)
5.6 Middle East and Africa (GCC and Rest of MEA)
5.6.1 Middle East and Africa Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015- 2025 (US$)
5.6.2 Middle East and Africa Atopic Dermatitis (AD) Treatment Market, by Country, 2015- 2025 (US$)

Chapter 6 Company Profiles
6.1 AbbieVie Inc.
6.2 Encore Dermatology Inc.
6.3 F. Hoffmann-La Roche AG
6.4 Glaxosmithkline plc.
6.5 LEO Pharma A/S
6.6 Medimmune LLC. (Astrazeneca)
6.7 Novartis AG
6.8 Pfizer Inc.
6.9 Regeneron Pharmaceuticals Inc.
6.10 Sanofi S.A.
6.11 Valeant Pharmaceuticals Inc.

List of Figures
Fig. 1 Atopic Dermatitis (AD) Treatment Market: Research Methodology
Fig. 2 Global Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2016 (US$ Bn)
Fig. 3 Global Atopic Dermatitis (AD) Treatment Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition: Global Atopic Dermatitis (AD) Treatment Market, by Geography, 2016
Fig. 5 Attractive Investment Proposition: Global Atopic Dermatitis (AD) Treatment Market, by Drug type, 2016
Fig. 6 Global Corticosteroids Market, 2015 - 2025 (US$ Bn)
Fig. 7 Global Calcineurin Inhibitors Market, 2015 - 2025 (US$ Bn)
Fig. 8 Global Antihistamines Market, 2015 - 2025 (US$ Bn)
Fig. 9 Global Immunomodulators Market, 2015 - 2025 (US$ Bn)
Fig. 10 Global Interleukin Inhibitors Market, 2015 - 2025 (US$ Bn)
Fig. 11 Global Topical Phosphodiesterase-4 (PDE-4) Inhibitors Market, 2015 - 2025 (US$ Bn)
Fig. 12 Global Antiviral agents Market, 2015 - 2025 (US$ Bn)
Fig. 13 Global Antibiotics Market, 2015 - 2025 (US$ Bn)

List of Tables
Table 1 Market Positioning of Key Players in Global Atopic Dermatitis (AD) Treatment Market
Table 2 Global Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015 - 2025 (US$ Bn)
Table 3 Top 3 Countries in Global Atopic Dermatitis (AD) Treatment Market, 2015 - 2025 (US$ Bn)
Table 4 Global Anti-inflammatory agents in Atopic Dermatitis (AD) Treatment, 2015 - 2025 (US$ Bn)
Table 5 Global Atopic Dermatitis (AD) Treatment Market, by Geography, 2015 - 2025 (US$ Bn)
Table 6 North America Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
Table 7 North America Atopic Dermatitis (AD) Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 8 Europe Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
Table 9 Europe Atopic Dermatitis (AD) Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 10 Asia Pacific Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
Table 11 Asia Pacific Atopic Dermatitis (AD) Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 12 Latin America Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
Table 13 Latin America Atopic Dermatitis (AD) Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 14 Middle East and Africa Atopic Dermatitis (AD) Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
Table 15 Middle East and Africa Atopic Dermatitis (AD) Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 16 AbbieVie Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 17 Encore Dermatology Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 18 F. Hoffmann-La Roche AG: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 19 Glaxosmithkline plc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 20 LEO Pharma A/S: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 21 Medimmune LLC. (Astrazeneca): Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 22 Novartis AG: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 23 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 24 Regeneron Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 25 Sanofi S.A.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Table 26 Valeant Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbieVie Inc.
  • Encore Dermatology Inc.
  • F. Hoffmann-La Roche AG
  • Glaxosmithkline plc.
  • LEO Pharma A/S
  • Medimmune LLC. (Astrazeneca)
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi S.A.
  • Valeant Pharmaceuticals Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll